Ex vivo inhibition of LRRK2 in human PBMC assessed as unbound concentration required for reduction in LRRK2 phosphorylation at Ser935 residue incubate...

Basic Information

ID: ALA5044165

Type: Binding

Description: Ex vivo inhibition of LRRK2 in human PBMC assessed as unbound concentration required for reduction in LRRK2 phosphorylation at Ser935 residue incubated for 90 mins by MSD assay

Format: BAO_0000219

Organism: Homo sapiens

Cell type: PBMC

Target:  Leucine-rich repeat serine/threonine-protein kinase 2(ALA1075104)

Document:  ALA5042510

Ex vivo inhibition of LRRK2 in human PBMC assessed as unbound concentration required for reduction in LRRK2 phosphorylation at Ser935 residue incubated for 90 mins by MSD assay: 1

Activity Charts

Compound Summary

Parent Molecular WeightALogPPolar Surface Area
504.974.054.05
543.384.344.34
457.294.874.87